PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2017Clinical and Experimental Vaccine Research208 citationsOpen Access

Enterovirus 71 infection and vaccines

EYEun-Je YiSYShin Yun-juJKJeong-Hwan Kim

Structured PICO

P
Population
Young children susceptible to Hand, foot and mouth disease (HFMD) caused by enterovirus 71 (EV71)
I
Intervention
Enterovirus 71 (EV71) vaccines

This review highlights the urgent need for and progress in developing vaccines against enterovirus 71 to prevent severe complications of hand, foot and mouth disease.

Abstract

Hand, foot and mouth disease (HFMD) is a highly contagious viral infection affecting young children during the spring to fall seasons. Recently, serious outbreaks of HFMD were reported frequently in the Asia-Pacific region, including China and Korea. The symptoms of HFMD are usually mild, comprising fever, loss of appetite, and a rash with blisters, which do not need specific treatment. However, there are uncommon neurological or cardiac complications such as meningitis and acute flaccid paralysis that can be fatal. HFMD is most commonly caused by infection with coxsackievirus A16, and secondly by enterovirus 71 (EV71). Many other strains of coxsackievirus and enterovirus can also cause HFMD. Importantly, HFMD caused by EV71 tends to be associated with fatal complications. Therefore, there is an urgent need to protect against EV71 infection. Development of vaccines against EV71 would be the most effective approach to prevent EV71 outbreaks. Here, we summarize EV71 infection and development of vaccines, focusing on current scientific and clinical progress.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yi et al. (2017) studied this question.

synapsesocial.com/papers/69d56ec075589c71d767d5b8https://doi.org/10.7774/cevr.2017.6.1.4
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1EV-A71 Infections: Life Cycle and Prevention Strategies2023
  2. 2Status of research and development of vaccines for enterovirus 712016 · 56 citations
  3. 3Human enterovirus 71 and hand, foot and mouth disease2010 · 252 citations
  4. 4Recombinant Human Enterovirus 712004 · 68 citations
  5. 5The effectiveness and impact of the enterovirus 71 vaccine on the onset of hand, foot, and mouth disease in children aged ≤5 years: A 7-year study2024 · 5 citations